在心脏手术期间输血前热血素复合物缩剂或血输血后产生血栓
Ian J Welsby1, Darrell R Schroeder2, Kamrouz Ghadimi3
1Department of Anesthesiology & Critical Care, Duke University Medical Center, Erwin Road, Durham, NC, 27710, USA. ian.welsby@duke.edu.
Journal of thrombosis and thrombolysis
|December 5, 2024
概括
与等离子体相比,四因子前激素复合缩剂 (PCC) 在心脏手术后更快地恢复了血栓生成 (TG). 这项研究发现,PCC在治疗后的早期改善了TG参数,而不会导致高凝血.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 输血医学 输血医学
背景情况:
- 在心脏外科手术中,心肺旁路术 (CPB) 后,血栓生成 (TG) 的减少有助于凝血病和出血.
- 血或四因子前列红素复合缩剂 (PCC) 用于治疗出血,但它们对TG恢复的影响尚未完全理解.
研究的目的:
- 为了比较PCC与血在恢复心脏手术的成年患者中血栓生成 (TG) 的疗效.
- 分析PCC和血对CPB后凝血因子水平的影响.
主要方法:
- 一个随机对照试验的基于实验室的二次分析.
- 在治疗后的序列时间点评估血栓生成 (TG) 参数和凝血因子水平.
- 在99名成人心脏手术患者中,PCC (15 IU/kg) 与血 (10-15 ml/kg) 的比较.
主要成果:
- 与血组相比,PCC组在治疗后的早期显示出明显更高的内源性血栓激素潜力 (ETP) 和高峰TG.
- 两组在术后第一天达到相似的TG值.
- 在治疗后早期,PCC组的C,S蛋白和因子II,VII,IX和X的水平较高.
结论:
- 在心脏手术后的早期术后期,PCC的使用比血更快地恢复血栓生成 (TG).
- 在PCC治疗中,没有实验室证据表明高凝固性.
- 研究结果支持PCC作为一种有效的选择,用于管理CPB后的凝血性出血.
相关概念视频
Coagulation
4.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.7K
Clot Retraction and Fibrinolysis
4.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.0K
Extrinsic and Intrinsic Pathways of Hemostasis
5.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Introduction to Hemostasis
5.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.6K
Formation of the Platelet Plug
4.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.4K


